Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 15.96 M15.94 M16.18 M17.64 M 65.72 M Research & development ———— — Operating income 968 K132 K1.5 M3.87 M 6.46 M Non-Operating Income, Total 1.36 M-328 K-302 K282 K 1.01 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 458 K-334 K-315 K283 K 92 K Unusual income/expense 904 K6 00013 K-1 000 922 K Pretax income 2.33 M-196 K1.2 M4.15 M 7.48 M Equity in earnings ———— — Taxes 421 K-75 K302 K447 K 1.09 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 1.91 M-121 K893 K3.7 M 6.38 M Discontinued operations ———— — Net income 1.91 M-121 K893 K3.7 M 6.38 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 1.91 M-121 K893 K3.7 M 6.38 M Basic earnings per share (Basic EPS) 0.25-0.020.13— — Diluted earnings per share (Diluted EPS) 0.15-0.010.070.29 0.5 Average basic shares outstanding 14.44 M14.47 M14.5 M14.53 M — Diluted shares outstanding 12.54 M12.46 M12.7 M12.69 M — EBITDA 1.94 M1.07 M2.49 M3.81 M 9.31 M EBIT 968 K132 K1.5 M2.92 M 5.52 M Cost of revenue 37.68 M36.21 M37.79 M45.54 M 157.22 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 971 K937 K989 K892 K 3.79 M